Weiss Asset Management LP Amgen Inc Transaction History

Weiss Asset Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $3.6 Million - $4.06 Million	16,050 New	16,050 $3.62 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $4.54 Million - $5.32 Million	-21,401 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $5 Million - $5.55 Million	21,401 New	21,401 $5.22 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $260,731 - $335,129	-1,378 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $123,269 - $147,702	-708 Reduced 33.94%	1,378 $267,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $33,006 - $38,691	198 Added 10.49%	2,086 $384,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $341,482 - $384,925	1,888 New	1,888 $359,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Weiss Asset Management LP with notifications on news.